Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 2Recruiting 1Not yet recruiting 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Carcinoma, Non-Small-Cell Lung 5Neoplasms 3Lung Neoplasms 3Carcinoma, Hepatocellular 3Brain Neoplasms 3Urinary Bladder Neoplasms 2Prostatic Neoplasms 2Neoplasm Metastasis 2Colorectal Neoplasms 2Breast Neoplasms 2Stomach Neoplasms 1Papillomavirus Infections 1Pancreatic Neoplasms 1Neoplasms, Second Primary 1NSCLC 1Lung Metastases 1Locally Advanced Pancreatic Cancer 1Kidney Neoplasms 1Hematologic Neoplasms 1Esophageal Neoplasms 1Carcinoma, Squamous Cell 1Carcinoma, Renal Cell 1Carcinoma, Pancreatic Ductal 1Cancer Pain 1CRC 1Anatomic Stage IV Breast Cancer AJCC v8 1

Interventions

Drug Therapy 3Carboplatin 3Surgical Procedures, Operative 2Pemetrexed 2Paclitaxel 2Cisplatin 2toripalimab 1tislelizumab 1surufatinib 1osimertinib 1lorlatinib 1anlotinib 1aflutinib 1Radiotherapy 1Radiosurgery 1Platinum Compounds 1Neoadjuvant Therapy 1Diphenhydramine 1Cryotherapy 1Chemotherapy, Adjuvant 1Chemoradiotherapy 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × NSCLC × Radiosurgery × Clear all
NCT07379398 2026-04-29

Iparomlimab and Tuvonralimab Injection Combined With SBRT in Patients With Early-Stage Non-Small Cell Lung Cancer

Tianjin Medical University Cancer Institute and Hospital

Phase 2 Not yet recruiting
28 enrolled
Thoracic

NSCLC

Data powered by HemOnc (CC BY 4.0) Colophon âš¡